Combined Chemotherapy and Radiation (RT) Improves Survival for Node-Positive, High Grade Endometrial Cancer

被引：0
|
作者：
Lee, L. J. [1 ]
Viswanathan, A. N. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.1184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival
    Samson, Pamela
    Puri, Varun
    Lockhart, A. Craig
    Robinson, Clifford
    Broderick, Stephen
    Patterson, G. Alexander
    Meyers, Bryan
    Crabtree, Traves
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (04): : 1725 - 1735
  • [32] The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma
    Tamirisa, Nina Prabha
    Vernia, Hannah
    Thomas, Samantha M.
    Westbrook, Kelly E.
    Greenup, Rachel Adams
    Plichta, Jennifer Kay
    Rosenberger, Laura Horst
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    Fayanju, Oluwadamilola Motunrayo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma
    Tamirisa, Nina
    Williamson, Hannah V.
    Thomas, Samantha M.
    Westbrook, Kelly E.
    Greenup, Rachel A.
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    Fayanju, Oluwadamilola M.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 132 - 141
  • [34] Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
    Taghian, AG
    Assaad, SI
    Niemierko, A
    Floyd, SR
    Powell, SN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02): : 386 - 391
  • [35] High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival
    Sood, Akshay
    Keeley, Jacob
    Palma-Zamora, Isaac
    Novara, Giacomo
    Elshaikh, Mohamed
    Jeong, Wooju
    Hensley, Patrick
    Navai, Neema
    Peabody, James
    Trinh, Quoc-Dien
    Rogers, Craig G.
    Menon, Mani
    Abdollah, Firas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 62.e1 - 62.e11
  • [36] CHEMOTHERAPY IMPROVES DISEASE-FREE SURVIVAL IN STAGE IIIC LOW/INTERMEDIATE-GRADE BUT NOT IN HIGH-GRADE ENDOMETRIAL CANCER
    Bakkum-Gamez, J.
    Dowdy, S.
    Jatoi, A.
    Keeney, G.
    Mariani, A.
    Weaver, A.
    McGree, M.
    Cliby, W.
    Martin, J.
    Podratz, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [37] THE VALUE OF NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE-POSITIVE BLADDER CANCER
    Werntz, Ryan
    Smith, Zach
    Packiam, Vignesh
    Riedinger, Chris
    Fantus, Jake
    Smith, Norm
    Steinberg, Gary
    JOURNAL OF UROLOGY, 2018, 199 (04): : E314 - E315
  • [38] Dose-dense chemotherapy for node-positive breast cancer
    Citron, ML
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (03) : 227 - 227
  • [39] Node-positive breast cancer: Which are the best chemotherapy regimens?
    Janni, Wolfgang
    Rack, Brigitte
    Harbeck, Nadja
    Bauerfeind, Ingo
    Sommer, Harald
    Friese, Klaus
    BREAST CARE, 2008, 3 (04) : 244 - 250
  • [40] Selection of adjuvant chemotherapy for treatment of node-positive breast cancer
    Trudeau, M
    Charbonneau, F
    Gelmon, K
    Laing, K
    Latreille, J
    Mackey, J
    McLeod, D
    Pritchard, K
    Provencher, L
    Verma, S
    LANCET ONCOLOGY, 2005, 6 (11): : 886 - 898
12345